Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks
Exercise can also improve your heart and lung health." Walzer further addressed concerns surrounding muscle preservation, explaining that weight loss alone does not guarantee a healthier physique without adequate nutrition and physical activity
Privately prescribed GLP-1s may not appear on the patients medical history so if a patient presents with these symptoms, healthcare professionals should enquire about GLP-1 use
Paired-end sequencing of the library was performed using the Illumina HiSeq platform (Illumina Inc., San Diego, CA, USA)